Diisopropylethylamine → (+/-) tert-butyl 2-methyl-4-(4-nitro-1-(2,2,2-trifluoroethyl)-1H-pyrazol-5-yl)piperazine-1-carboxylate
Reaction equation
Br[C:2]1[N:6]([CH2:7][C:8]([F:11])([F:10])[F:9])[N:5]=[CH:4][C:3]=1[N+:12]([O-:14])=[O:13].[CH3:15][CH:16]1[CH2:21][NH:20][CH2:19][CH2:18][N:17]1[C:22]([O:24][C:25]([CH3:28])([CH3:27])[CH3:26])=[O:23].CCN(C(C)C)C(C)C>CCO>[CH3:15][CH:16]1[CH2:21][N:20]([C:2]2[N:6]([CH2:7][C:8]([F:11])([F:10])[F:9])[N:5]=[CH:4][C:3]=2[N+:12]([O-:14])=[O:13])[CH2:19][CH2:18][N:17]1[C:22]([O:24][C:25]([CH3:26])([CH3:28])[CH3:27])=[O:23]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
A solution of Intermediate 39, 5-bromo-4-nitro-1-(2,2,2-trifluoroethyl)-1H-pyrazole (550 mg, 2.01 mmol), (±) tert-butyl 2-methylpiperazine-1-carboxylate (403 mg, 2.01 mmol), DIPEA (2 mL) in EtOH (6 mL) was stirred at 130° C. for 2 hours in a microwave oven. The reaction mixture was concentrated under reduced pressure to give a residue. The residue was purified by silica gel chromatography using PE:EtOAc (1:1) as eluting solvents to afford tert-butyl (±)-2-methyl-4-(4-nitro-1-(2,2,2-trifluoroethyl)-1H-pyrazol-5-yl)piperazine-1-carboxylate as yellow solid (377 mg, 48%). MS (ESI) m/z: 394 [M+H+].
Workup
- concentrationThe reaction mixture was concentrated under reduced pressure
- customto give a residue
- customThe residue was purified by silica gel chromatography
- washEtOAc (1:1) as eluting solvents
Sources & evidence
- ORD record
- ord-94417fb8ee8a449f95dd6b396bdc21e4
- Source dataset
- uspto-grants-2013_12
- Patent number
- US08614206B2
Reaction notes
Loading…